George Nomikos - Nov 1, 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Chief Medical Officer
Signature
/s/ George Nomikos
Stock symbol
LPCN
Transactions as of
Nov 1, 2022
Transactions value $
$50,750
Form type
4
Date filed
11/8/2022, 10:57 AM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $50.8K +125K $0.41 125K Nov 1, 2022 Common Stock 125K $0.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of November 1, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.